FPF
MDGL icon

FNY Partners Fund’s Madrigal Pharmaceuticals MDGL Stock Holding History

FNY Partners Fund’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$39K Buy
+335
New +$41.4K 0.02% 197
2017
Q4 		– Sell
-1,500
Closed -$67K – 535
2017
Q3 		$67K Buy
+1,500
New +$28.1K 0.01% 263

Other funds holding MDGL

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FNY Partners Fund's MDGL Position: Q1 2018 in Review

FNY Partners Fund opened a new position in Madrigal Pharmaceuticals (MDGL) in Q1 2018: 335 shares worth $39K. The stake represents 0.02% of the portfolio and ranks #197 among its holdings. This is a return to the name: FNY Partners Fund previously reported a position in MDGL as recently as Q3 2017.

FNY Partners Fund first reported a position in MDGL in Q3 2017 and has held it in 2 quarters since. The position peaked at $67K in Q3 2017. 100 funds tracked by Wall St. Rank hold MDGL as of Q1 2018.

  • FNY Partners Fund held 335 shares of Madrigal Pharmaceuticals worth $39K as of Q1 2018.
  • Madrigal Pharmaceuticals was a new FNY Partners Fund position in Q1 2018.
  • Madrigal Pharmaceuticals made up 0.02% of FNY Partners Fund's portfolio in Q1 2018, its #197 holding.
  • FNY Partners Fund first reported a position in Madrigal Pharmaceuticals in Q3 2017 and has held it in 2 quarters since.
  • FNY Partners Fund's Madrigal Pharmaceuticals position peaked at $67K in Q3 2017.
  • 100 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2018.

Based on FNY Partners Fund's 13F filing for Q1 2018, filed 18 Apr 2018.